Analysts have been eager to weigh in on the Financial sector with new ratings on S&P Global (SPGI – Research Report), Victory Capital ...
Truist Securities increased the price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ: VRTX), a $121 ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares.
Morgan Stanley (NYSE:MS) adjusted its outlook for Victory Capital Holdings, Inc. (NASDAQ: NASDAQ:VCTR), increasing the firm's price target from $63.00 to $68.00. The investment bank maintained its ...
Davis Selected Advisers' 13F portfolio saw changes with stake increases in tech and travel, while reducing in financial and ...